CORRECTION: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease

Date
2020-03-02
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Abstract

Correction to: Translational Psychiatry

10.1038/s41398-020-0709-x published online 03 February 2020

The original article contained few errors: Hanuma K. Karnati’s name was misstated in the author list, references 2 and 55 referred to the wrong sources, and the authors wanted to expand on their discussion of ChEIs on page 13. These errors have all been updated in the XML, PDF, and HTML versions of this article.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Ray B, Maloney B, Sambamurti K, et al. Correction: Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020;10(1):81. Published 2020 Mar 2. doi:10.1038/s41398-020-0757-2
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Translational Psychiatry
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}